screamdc
17 years ago
Insider buying
http://www.pinksheets.com/edgar/GetFilingHtml?FilingID=5385117
Common Stock, par value $0.01 per share 08/20/07 P 3,000 A $10 19,500 D
Common Stock, par value $0.01 per share 08/21/07 P 2,000 A $10.03 21,500 D
Common Stock, par value $0.01 per share 08/21/07 P 3,000 A $10.18 24,500 D
screamdc
17 years ago
UPDATE 1-RESEARCH ALERT-Citigroup upgrades Physicians Formula
Adds details, share movement) Aug 20 (Reuters) - PHYSICIANS FORMULA HOLDINGS INC (FACE.O: Quote, Profile, Research) Current Prior
Rating Buy Hold
Price Target $13 $12 --Citigroup said it still expects the cosmetics company to
deliver 16 percent sales growth in 2008, despite the brokerage
having recently revised down its expectations for the company's
growth. --The brokerage raised its earnings estimates for the
company, saying the coming year would not be as pressured by
initial store setup expenses at Wal-Mart Stores Inc (WMT.N: Quote, Profile, Research) as
in the second quarter of 2007. --Citigroup now expects Physicians Formula to earn 2 cents
a share, compared with its previous view for a break even, in
the second quarter of 2008. For fiscal 2008, it expects the
company to earn 69 cents per share, up from the previous view
for a profit of 67 cents a share. --Shares of the company were up almost 11 percent at $10.03
in morning trade on the Nasdaq.
(Reporting by Neha Singh in Bangalore)
http://www.reuters.com/article/marketsNews/idUKBNG8160120070820?rpc=44
screamdc
17 years ago
AP
Out of the Gate: Physicians Formula Up
Monday August 20, 10:02 am ET
Analyst Upgrades Physicians Formula Holdings Stock on Prediction of Strong 2008 Sales Growth
NEW YORK (AP) -- Shares of Physicians Formula Holdings Inc. gained ground Monday after a Citi Investment Research analyst upgraded the stock to "Buy," saying the cosmetics company will post strong sales growth in 2008.
The stock has lost more than half its value since May 8, when Physicians Formula said its second-quarter results would miss analyst estimates. The company cut its quarterly and full-year outlook in July, and lowered its 2007 forecast again on Tuesday.
Physicians Formula began trading in November, and set a low of $8.26 per share on Thursday.
Wendy Nicholson upgraded the stock to "Buy" from "Hold," and raised her price target to $13 per share from $12. She thinks the company's sales will grow 16 percent in 2008 -- better than its competitors -- and said Physicians Formula will increase its market share despite weak U.S. consumer spending.
Three analysts report a "Buy"-equivalent rating on the stock to Thomson Financial, while one gives a "Neutral" rating.
Shares advanced 82 cents, or 4.5 percent, to $9.87 in morning trading.
http://biz.yahoo.com/ap/070820/physicians_formula_out_of_the_gate.html?.v=1
screamdc
17 years ago
Physicians Formula Holdings Upped To Buy From Hold At CitiLast update: 8/20/2007 7:12:04 AM(END) Dow Jones NewswiresAugust 20, 2007 07:12 ET (11:12 GMT)Copyright © 2007 MarketWatch, Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
News provided by Dow Jones NewswiresSM, PR News Wire™ and Business Wire™. Dow Jones Newswires is a service mark of Dow Jones & Company. PR News Wire is a Trademark of PR Newswire Association, Inc. Business Wire is a registered trademark and service mark of Business Wire.
Ameritrade is not responsible for the quality and suitability of third party financial or investment information or services. Please consult other sources of information and consider your individual financial position and goals before making an investment decision. Ameritrade, Division of Ameritrade, Inc., member NASD/SIPC. Ameritrade and Ameritrade logos are trademarks or registered trademarks of Ameritrade IP Company, Inc. 2002 Ameritrade IP Company, Inc. All rights reserved. Used with permission.
screamdc
17 years ago
Physicians Formula Holdings, Inc. Announces that Executive Zvi Eiref to Join the Company's Board as an Independent Director
Last Update: 4:05 PM ET Aug 7, 2007
AZUSA, Calif., Aug 07, 2007 /PRNewswire-FirstCall via COMTEX/ -- Physicians Formula Holdings, Inc. today announced that it has appointed Zvi Eiref to join the Company's Board of Directors as an independent director effective August 6, 2007. The Company also announced that Walter G. Kortschak resigned as a director, effective August 6, 2007, to devote more time to his other business activities.
Mr. Eiref brings over 30 years of operating experience in the consumer packaged goods industry to his Board position. During his 20-year tenure as Chief Financial Officer of Church & Dwight Co., Inc. Mr. Eiref worked with the executive team to help shape overall corporate strategy and transform Church & Dwight from a small single product company to a broad-based household and personal care company with annual sales of $2 billion. From 1988 to 1995 Mr. Eiref served as Chief Financial Officer of Chanel, Inc., where he professionalized the finance and systems functions during a period of very rapid growth in Chanel's fragrance, cosmetics and ready-to-wear businesses. Earlier in his career, Mr. Eiref worked for Unilever and Arthur Andersen in Europe, and he is an English Chartered Accountant.
"I am very pleased to welcome Zvi to our Board and I look forward to working closely with him as we continue to extend the Physicians Formula brand," said Ingrid Jackel, Chief Executive Officer. "Zvi brings a wealth of public company operational and financial experience, and his insight will be invaluable to us as we continue to launch new products and expand our market share. I would also like to thank Walter for his valued input and contribution over the past four years."
"I am honored to serve on the Board of Physicians Formula," said Zvi Eiref. "With their strong management team and leadership position in the masstige market, the Company is well positioned for long-term sustainable growth. I look forward to working closely with the Company's executive team and other Board members."
http://www.marketwatch.com/news/story/physicians-formula-holdings-inc-announces/story.aspx?guid=%7B9...
screamdc
17 years ago
Ownership Activity
Description # of Holders Shares
Total Positions 69 14,018,772
New Positions 23 2,479,071
Soldout Positions 26 -2,239,511
Net Position Change 5 2,096,236
Buyers 50 5,049,238
Sellers 45 -2,953,002
http://moneycentral.msn.com/ownership?Symbol=FACE
screamdc
17 years ago
Physicians Formula Holdings, Inc. Announces Second Quarter 2007 Conference Call to be held on Monday, August 13, 2007
Last Update: 4:01 PM ET Jul 31, 2007
AZUSA, Calif., July 31, 2007 /PRNewswire-FirstCall via COMTEX/ -- Physicians Formula Holdings, Inc. (FACE : physicians formula hldgs inc com
News , chart , profile , more
Last: 14.95+0.23+1.56%
4:22pm 07/31/2007
Delayed quote dataAdd to portfolio
Analyst
Create alertInsider
Discuss
Financials
Sponsored by:
FACE14.95, +0.23, +1.6%) today announced that the Company will host a conference call to discuss its results for the second quarter ended June 30, 2007, on Monday, August 13, 2007. The Company will issue an earnings announcement prior to the conference call.
The conference call is scheduled to begin at 2:00 pm Pacific Time on Monday, August 13, 2007. Participants may access the call by dialing 800-811- 8845 (domestic) or 913-981-4905 (international). In addition, the call will be webcast via the Company's Web site at www.physiciansformula.com, Investor Relations, where it will also be archived. A telephone replay will be available through Monday, August 27, 2007. To access the replay, please dial 888-203-1112 (domestic) or 719-457-0820 (international), passcode 2682414.
About Physicians Formula Holdings, Inc.
Physicians Formula is one of the fastest growing cosmetics companies operating in the mass market prestige, or "masstige", market. Under its Physicians Formula brand name, created in 1937, the Company develops, markets and distributes innovative, premium priced products for the mass market channel. Physicians Formula differentiates itself by addressing skin imperfections through a problem-solving approach, rather than focusing on changing fashion trends. Currently, Physicians Formula products are sold in over 26,000 stores throughout the U.S. including stores operated by Wal-Mart, Target, CVS, Walgreens and Albertsons.
(FACE/F)
Contact: John Mills / Anne Rakunas
Integrated Corporate Relations, Inc.
(310) 954-1100
SOURCE Physicians Formula Holdings, Inc.
John Mills or Anne Rakunas both of Integrated Corporate Relations, Inc., +1-310-954-1100, for Physicians Formula Holdings, Inc. http://www.physiciansformula.com/ Copyright (C) 2007 PR Newswire. All rights reserved
http://www.marketwatch.com/news/story/physicians-formula-holdings-inc-announces/story.aspx?guid=%7BE...
screamdc
17 years ago
New Venturesome Manufacturers with Specialty Offerings Giving the Makeup Industry a New Look, Says Mercanti Report
MINNEAPOLIS--(BUSINESS WIRE)--
Walk into any department store, and what's the first thing that greets you? Counter after counter of makeup. In the cosmetics industry, makeup, a $6 billion to $8 billion business in the U.S., is a steady growth category, with consistent yearly gains and mounting demand.
And while the makeup segment is dominated by three giants (L'Oreal, Procter & Gamble and Revlon), smaller companies enjoying faster growth potential are beginning to proliferate and make their mark, says the newly released monthly Mercanti Chronicle report by investment banking firm, The Mercanti Group.
"Successful private equity investments in makeup companies, such as Bare Essentials (NASDAQ: BARE) and Physician's Formula (NASDAQ: FACE), have recently been realized through initial public offerings," says the study by Mercanti Principal Josh Susser.
"Further, highly experienced private equity investors have recently invested in Philosophy, SmashBox and Stila. Each of these companies is capitalizing on a makeup market in flux, where small share gains have a dramatic impact on investment returns," the report states.
Noting that today 70% of women in the U.S. wear makeup, the comprehensive Mercanti report says that entrepreneurial and start-up companies have found ways to exploit the market's fragmentation within certain channels and niches. "In the process, they have created cult followings and significant shareholder value," it says.
Other changes are afoot, the report comments. While historically food, drug and mass retailers, along with department stores, have accounted for nearly all makeup sales, consumers are increasingly turning to other sources, such as the Internet, infomercials, home shopping channels and home marketing organizations. In addition, mass merchants and growing specialty retailers now offer prestige products, creating a significant "upper mass" or "mass-tige" market for luxury makeup goods, Mr. Susser observes.
The growth of the makeup market, which takes place in increments (future gains are expected to nearly match the rate of inflation, as compared to a 5% annual growth previously), is being driven by the appeal of home shopping channel offerings, aging Baby Boomers, enhanced makeup assortments among mass retailers, attractively priced private brands and favorable fashion trends.
"One cannot deny that makeup sales are driven by fashion trends," comments the report. Mr. Susser points out that as mascara and eye liner products have been more innovative in terms of color and effect than lipsticks, eye makeup sales increased 15% from 2004 to 2006, while lip makeup over the same period decreased 7%.
At the same time, consumers are seeking makeup that is natural and has health effects that help improve both body and mind. "In general, the natural makeup trend follows the overall trend toward purchasing natural and organic personal care products for both wellness and a specific function," the Mercanti Chronicle reports. "Consumers are persuaded by makeup products that are multi-functional or that include a pharmaceutical element, so-called cosmeceuticals."
"Research shows that American women today desire their makeup to better match their look. They also want it to be all-natural, hypo-allergenic, non-comedogenic, with nutrients, sunscreen and moisturizer," Mr. Susser concludes. "When they age, they want it to make them look younger. When they are young, they want it to make them look older. What it all adds up to from business and investment viewpoints, is that if makeup companies can find a product to fit individual groups of women, there are infinite opportunities."
screamdc
17 years ago
O/S 13,927,055
The number of shares outstanding of the registrant’s common stock, par value $.01 per share, as of May 10, 2007, was 13,927,055.
http://investor.physiciansformula.com/sec.cfm
Level up your trading with our powerful tools and real-time insights all in one place.
Ask ADVFN Intelligence (AI)
Penny Roger$
13 years ago
MLR_Lite
16 years ago
Hot Features
Premium
